Pfizer Sees Obesity Drugs Echoing Viagras Early Growth, CEO Says

Compartió un vínculo

2026-01-13 15:00:02

Pfizer CEO Albert Bourla in Davos, Switzerland, on May 25, 2022. Fabrice Coffrini/AFPPfizer is gearing up for a consumer-driven market for obesity drugs that could match the rapid growth it experienced

0 Commentarios 0 Acciones 17 Views